Skip to main content Accessibility help
×
Home

Information:

  • Access

Actions:

      • Send article to Kindle

        To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

        Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

        Find out more about the Kindle Personal Document Service.

        Trends in use of psychotropic medications among patients treated with cholinesterase inhibitors in Japan from 2002 to 2010 — Corrigendum
        Available formats
        ×

        Send article to Dropbox

        To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

        Trends in use of psychotropic medications among patients treated with cholinesterase inhibitors in Japan from 2002 to 2010 — Corrigendum
        Available formats
        ×

        Send article to Google Drive

        To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

        Trends in use of psychotropic medications among patients treated with cholinesterase inhibitors in Japan from 2002 to 2010 — Corrigendum
        Available formats
        ×
Export citation

In the above published article by Okumura et al., the authors apologize for errors in the 2nd, 3rd and 4th columns of Table 2. The corrected Table 2 is given below.

Table 2 Trends in psychotropic visits by psychotropic classes

Note. BZDs = benzodiazepines; CI = confidence interval; FGAs = first-generation antipsychotics; NGAs = new-generation antidepressants; SGAs = second-generation antipsychotics; TCAs = tricyclic antidepressants.

* p < .05

The following corrections related to Table 2 have also been made to the article:

ABSTRACT (Results)

Results: In 2008–2010, the most prevalently prescribed psychotropic medications to patients with dementia were sedatives-hypnotics (27.3%), antipsychotics (21.3%), antidepressants (11.4%), and mood-stabilizers (2.8%). Between 2002–2004 and 2008–2010, use of second-generation antipsychotics increased from 4.9% to 11.2%, while use of first-generation antipsychotics decreased from 17.4% to 12.1%.

Results: (paragraph 4)

In 2008–2010, the most prescribed psychotropic classes were sedatives-hypnotics (27.3%), antipsychotics (21.3%), antidepressants (11.4%), and mood-stabilizers (2.8%).

Results: (paragraph 5)

Figure 1 shows major results of trends in antipsychotics use between 2002 and 2010. Amongst the antipsychotics, prevalent utilization of SGAs markedly increased from 4.9% to 11.2% (OR 2.95, 95% CI 2.44–3.59), while the use of FGAs declined from 17.4% to 12.1% (OR 0.71, 95% CI 0.62–0.80) between 2002–2004 and 2008–2010.

Results: (paragraph 6)

Amongst the antidepressants, prevalent utilization of NGAs slightly increased from 6.0% to 7.1% (OR 1.36, 95% CI 1.13–1.65), and other antidepressants increased from 3.6% to 3.8% (OR 1.37, 95% CI 1.08–1.75) between 2002–2004 and 2008–2010.

Results: (paragraph 8)

Amongst the sedatives-hypnotics, the most prescribed subclasses were hypnotic BZDs (17.2%), Sedative BZDs (11.9%), z-drugs (7.4%), and other sedatives-hypnotics (1.3%) in 2008–2010. Between 2002–2004 and 2008–2010, the prevalent utilization of z-drugs increased from 4.7% to 7.4% (OR 1.67, 95% CI 1.37–2.04) although use of any BZDs, sedative BZDs, hypnotic BZDs, and other sedatives-hypnotics remained stable.

Discussion (paragraph 1)

Our study yielded six major findings using data collected from outpatients with dementia. First, we observed a 1.1-fold increase in the extensive use of antipsychotics (about 21%) over time.

Discussion (paragraph 3)

We observed a stable non-negligible use of sedative BZDs (12%) over time.

The corrections do not alter the conclusions of this article and the authors regret these errors.

Reference

Okumura, Y., Togo, T. and Fujita, J. Trends in use of psychotropic medications among patients treated with cholinesterase inhibitors in Japan from 2002 to 2010. International Psychogeriatrics, Published online, 12 September 2014, doi: 10.1017/S1041610214001975.